NCT05532891View on ClinicalTrials.gov

Bariatric Surgery and COVID-19

CompletedOBSERVATIONAL
Enrollment

11,545

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

April 1, 2021

Study Completion Date

April 1, 2021

Conditions
COVID-19Bariatric Surgery Candidate
Interventions
OTHER

COVID-19 pandemic

Pandemic group underwent surgery during the COVID-19 pandemic. Pre-pandemic group underwent surgery prior to the pandemic.

Trial Locations (1)

W2 1NY

Department of Surgery and Cancer, Imperial College London, London

All Listed Sponsors
collaborator

The Royal College of Surgeons of England

OTHER

lead

Imperial College London

OTHER

NCT05532891 - Bariatric Surgery and COVID-19 | Biotech Hunter | Biotech Hunter